Showing 161 - 180 results of 4,768 for search 'Li Chinese', query time: 0.11s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168
  9. 169
  10. 170

    Molecular Characterization and Risk Factors of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Isolated from Chinese Tertiary Hospital by Zhu R, Li J, Lian S, Li Y, Cai M, Cao Y, Xu X

    Published 2025-01-01
    “…Rongping Zhu,1,* Ju Li,2,* Siyan Lian,2,* Yishan Li,3 Meili Cai,2 Yingping Cao,2 Xiaohong Xu2,4 1Department of Blood Transfusion, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, 350001, People’s Republic of China; 2Department of Laboratory Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, People’s Republic of China; 3Anxi County Traditional Chinese Medicine Hospital, Quanzhou, Fujian, 362000, People’s Republic of China; 4Fujian Medical University Union Clinical College, Fuzhou, Fujian, 350001, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiaohong Xu; Yingping Cao, Department of Clinical Laboratory, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, People’s Republic of China, Tel +86 13959192290 ; +86 13365910806, Email vancy1988@163.com; caoyingping@aliyun.comBackground: Therefore, the objectives of this study were to investigate the prevalence of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) in Fujian Medical University Union Hospital, identify their genetic characters, characterize their resistance profiles, and identify risk factors for their infection to improve prevention and treatment strategies for CR-hvKp in the area.Methods: Between January 2021 and January 2022, clinically identified carbapenem-resistant Klebsiella pneumoniae (CRKp) isolates were collected. …”
    Get full text
    Article
  11. 171
  12. 172
  13. 173
  14. 174
  15. 175

    A Randomized, Double-Blind, Placebo-Controlled Trial Protocol Using the Fuzhengxiaoliu Patch for the Management of Primary Liver Cancer Pain by Li S, Wang B, Deng J, Li H, Wu Y, Fang Y, Yan B, Chen Y

    Published 2025-01-01
    “…Siman Li,1 Binding Wang,1 Jiayao Deng,2 Haiyan Li,2 Yong Wu,3 Yu Fang,2 Bohua Yan,2 Yu Chen2 1School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan, People’s Republic of China; 2Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People’s Republic of China; 3Chengdu Zhongxiang Pharmaceutical Technology Co., Ltd., Chengdu, Sichuan, People’s Republic of ChinaCorrespondence: Bohua Yan; Yu Chen, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People’s Republic of China, Email yanbohuagcp@163.com; 735405661@qq.comObjective: Chronic pain strongly affects the quality of life of patients with liver cancer pain. …”
    Get full text
    Article
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180